Position in TXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,442,314
+$28,965,223 QoQ
Shares Held
2,019,883
-11.5% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $576,060,759 across 26 Medical Devices names. TXG ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
2,772,232 | $250,776,106 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
1,862,023 | $119,188,092 | |
| 3 | TXG |
10x Genomics, Inc.
This page
|
2,019,883 | $77,442,314 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
2,006,429 | $30,277,013 | |
| 5 | ATEC |
Alphatec Holdings, Inc.
|
3,352,133 | $28,995,950 | |
| 6 | AXGN |
Axogen, Inc.
|
386,423 | $17,848,878 | |
| 7 | NVCR |
NovoCure Ltd
|
1,164,072 | $17,635,690 | |
| 8 | VREX |
Varex Imaging Corp
|
479,785 | $5,004,157 |
All Filings in TXG
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,442,314 | 2,019,883 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,477,091 | 2,283,424 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $43,058,383 | 2,639,999 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,461,991 | 2,947,989 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $27,765,817 | 2,397,739 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,185,491 | 1,166,723 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $450,430 | 31,367 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $1,970,304 | 101,301 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,646,865 | 97,172 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||